This week’s approval expands Seldardsi indications to treat adults with Crohn’s disease and ulcerative colitis.

New real-world data suggest that physicians are cautious about prescribing the prostacyclin-receptor agonist Uptravi ...

A panel of speakers demonstrated different ways technology and artificial intelligence (AI) could greatly expand access to ...

Pricing data shows that doctors serving these communities facing economic challenges are paid less by insurers, effectively ...

Romero, Samuel Nordberg, Martin Rosenzweig, and Carrie Jardine share insight on the future treatment landscape for TRD.

A new statistical models shed light on why some patients can extend the dosing interval with Eylea (aflibercept) from 8 weeks ...

Changes have been proposed to the quality payment program that could have ups and downs, but not, perhaps for some, until ...

Subgroup analyses of the PHOTON trial show visual acuity gains across subgroups by race, baseline visual acuity and retina ...

Dr Martin Rosenzweig discusses the importance of data collection to improve patient care in TRD as well as alternative payment models.

The list includes dengue fever, chikungunya, leptospirosis and Valley fever, says University of Washington professor Peter ...

University of Washington’s Peter Rabinowitz, M.D., M.P.H.. sees a world awash in emerging diseases and climate change data ...

Clinical and other trials for GLP-1 therapies have found an association between these drugs and diabetic retinopathy ...